Not available
Quote | Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR)
Last: | $25.04 |
---|---|
Change Percent: | -2.92% |
Open: | $23.58 |
Close: | $25.04 |
High: | $25.22 |
Low: | $23.33 |
Volume: | 1,293,855 |
Last Trade Date Time: | 05/15/2024 03:00:00 am |
News | Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR)
2024-05-14 07:08:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you’re wondering what stocks to buy this month, look no further. Every investor wants their stock picks to double in price. Yet, the reality is that the average annual S&P 500 ...
2024-05-13 10:30:04 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for ARWR on May 13, 2024 08:34AM ET. The previous analyst recommendation was Equal-Weight. ARWR was trading at $22.39 at issue of the analyst recommendation. The overall analyst consensus : ...
Message Board Posts | Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ARWR News Article - Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday | whytestocks | investorshangout | 04/25/2023 3:35:46 PM |
$ARWR still ascending. | MiamiGent | investorshub | 01/13/2023 4:36:57 PM |
whytestocks: $ARWR News Article - Arrowhead Pharmaceuticals Announces $25 Million Milestone Payment | whytestocks | investorshangout | 12/20/2022 4:25:49 PM |
Arrowhead is an amazing company. Gene silencing | jimmy667 | investorshub | 10/22/2022 8:11:09 AM |
whytestocks: $ARWR News Article - 5 Top Biotech Stocks To Watch In July 2022 | whytestocks | investorshangout | 06/30/2022 6:55:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Arrowhead Pharmaceuticals Inc. Company Name:
ARWR Stock Symbol:
NASDAQ Market:
2024-05-13 10:30:04 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for ARWR on May 13, 2024 08:34AM ET. The previous analyst recommendation was Equal-Weight. ARWR was trading at $22.39 at issue of the analyst recommendation. The overall analyst consensus : ...
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly fina...